9th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer

Many factors have transformed the landscape of prostate cancer over these last years. To start, there has been a growing recognition of the overtreatment of prostate cancer, with a shift towards expectant management prior to consideration of radical whole gland therapy for selected men with early stage prostate cancer. This understanding bodes well for focal therapy, as we have positioned it to be a minimally-invasive treatment that destroys the known area(s) of cancer, while preserving a man's continence and potency. Today, there is growing interest in focal therapy for kidney and prostate cancers by physicians and patients alike.

At the recent 8th International Symposium held in the Netherlands we saw the confidence and enthusiasm for incorporating real-time imaging into the diagnostic and treatment strategy for prostate and kidney cancer. In the coming year, we anticipate the continued exponential growth in new modalities and paradigms in the focal treatment of urogenital cancer.

The 2016 Symposium is presented by Duke University Medical Center, Durham, North Carolina, in collaboration with AMC University Hospital, Amsterdam, The Netherlands and USC Institute of Urology, Los Angeles CA.